drugset / Trial / NCT00030121

Carperitide in Acute Respiratory Distress Syndrome (ARDS)

NCT00030121 ↗

Phase 2 Completed Suntory Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).

Timeline

Start
1999-12
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Carperitide Peptide — —